SAN FRANCISCO--()--Dolby Laboratories, Inc. (NYSE:DLB) today announced the Company’s financial results for the fourth quarter and fiscal year ended September 29, 2006.
“We saw good growth for our core technologies in fiscal 2006, and we now go into fiscal 2007 focused on extending these technologies across additional markets, driving the adoption of newer Dolby technologies, and capitalizing on the Dolby brand, reputation, and business model to generate additional long-term growth opportunities”
For the fourth quarter, Dolby reported total revenue of $102.1 million, compared to $78.9 million for the fourth quarter of fiscal 2005, an increase of 29 percent. Fourth quarter net income was $25.2 million, or $0.22 per diluted share, compared to $16.8 million, or $0.15 per diluted share, for the fourth quarter of fiscal 2005.
For fiscal year 2006, Dolby reported total revenue of $391.5 million, compared to $328.0 million for fiscal year 2005. Net income for fiscal year 2006 was $89.5 million, or $0.80 per diluted share, compared to $52.3 million, or $0.50 per diluted share, for fiscal year 2005.
Net income for the fourth quarter of fiscal 2006 reflected stock-based compensation expense of $4.2 million compared to $2.7 million for the fourth quarter of fiscal 2005. Net income for fiscal 2006 reflected $19.1 million of stock-based compensation expense, compared with $14.2 million for fiscal 2005.
In connection with the Company’s IPO, Ray Dolby contributed to the Company all of his intellectual property rights related to the Company’s business, which he had previously licensed to the Company in exchange for royalty payments. As a result of the contribution, the Company’s royalty payments to Ray Dolby terminated in February 2005. Consequently, net income for fiscal 2006 did not include any royalty payments to Ray Dolby, while net income for fiscal 2005 reflected $11.1 million of royalty payments to Ray Dolby, net of taxes. Pro forma net income, which excludes these royalty payments, was $89.5 million, or $0.80 per diluted share, for the 2006 fiscal year, compared to $63.4 million, or $0.61 per diluted share, for fiscal 2005.
In its third quarter fiscal 2006 report on Form 10-Q, Dolby disclosed that approximately $10 million in royalties were expected from two existing licensees and that the Company would not recognize this estimated revenue until resolution of certain contractual matters with the licensees. In the fourth quarter of fiscal 2006, the Company resolved the contractual matters with one of the licensees and recognized revenue of $6.7 million related to prior quarters.
“We saw good growth for our core technologies in fiscal 2006, and we now go into fiscal 2007 focused on extending these technologies across additional markets, driving the adoption of newer Dolby technologies, and capitalizing on the Dolby brand, reputation, and business model to generate additional long-term growth opportunities,” said Bill Jasper, President and Chief Executive Officer of Dolby.
Guidance
For fiscal 2007, revenue is currently expected to be $420 million to $450 million. Net income is expected to be $95 million to $105 million. Earnings per diluted share are expected to be $0.83 to $0.92. While under FAS 123R, stock-based compensation expense may vary based on factors such as stock price or volatility, Dolby currently expects stock-based compensation expense for the full year to be $20 million to $22 million.
Pro Forma Information
Prior to the Company’s IPO in February of 2005, Ray Dolby retained ownership of the intellectual property he created related to the Company’s business and licensed those rights to the Company in exchange for royalty payments. In connection with the Company’s IPO, Ray Dolby contributed to the Company all of these intellectual property rights. The pro forma financial information included in this release gives effect to the asset contribution as though such transactions had been completed prior to the beginning of fiscal 2005. Specifically, the Company provides net income and earnings per diluted share excluding royalties paid to Ray Dolby. The Company believes these are important metrics as they represent profitability exclusive of the charges that have now been eliminated. The Company uses these metrics internally to measure its performance and believes these metrics may be meaningful for investors in analyzing the Company’s results of operations. A reconciliation of the Company’s actual results to these additional metrics is included in this release.
The Company’s Conference Call Information
Members of Dolby management will lead a conference call open to all interested parties to discuss Dolby Laboratories’ fourth quarter and fiscal 2006 financial results at 2:00 p.m. PT/5:00 p.m. ET, Thursday, November 9, 2006.
Access to the teleconference will be available over the Internet from http://investor.dolby.com/medialist.cfm or by dialing 800-289-0493. International callers can access the conference call at 913-981-5510.
A replay of the call will be available beginning at 5:00 p.m. PT on November 9, 2006 until 9 p.m. PT on November 16, 2006, at 888-203-1112 (international callers can access the replay by dialing 719-457-0820) and entering confirmation code 5722471. An archived version of the teleconference will also be available on Dolby Laboratories’ website, www.dolby.com.
Forward Looking Statements
Certain statements in this press release, including statements relating to Dolby’s expectations regarding revenue, net income, earnings per diluted share, and stock-based compensation expense for the fiscal year ending September 28, 2007 and Dolby’s expectations concerning extending its technologies into additional markets and driving the adoption of newer Dolby® technologies, and the benefits, including long-term growth opportunities, that may be derived therefrom are “forward-looking statements” that are subject to risks and uncertainties. These forward-looking statements are based on management's current expectations, and as a result of certain risks and uncertainties actual results may differ materially from those projected. The following important factors, without limitation, could cause actual results to differ materially from those in the forward-looking statements: risks associated with trends in DVD markets; pricing pressures; the development of the markets for PCs, broadcast, gaming, automotive, and AAC-based music device products that incorporate Dolby’s technologies; the timing of Dolby’s receipt of royalty reports and/or payments from its licensees; Dolby’s accuracy of calculation of royalties due to its licensors; Dolby's ability to develop, maintain, and strengthen relationships with industry participants; Dolby’s ability to develop and deliver innovative technologies in response to new and growing markets in the entertainment industry; competitive risks; risks associated with conducting business in China and other countries that have historically limited recognition and enforcement of intellectual property and contractual rights; risks associated with the health of the motion picture industry generally; the development and growth of the market for digital cinema and Dolby's ability to successfully penetrate this market; and other risks detailed in Dolby's Securities and Exchange Commission filings and reports, including the risks identified under the section captioned “Risk Factors” in its Annual Report on Form 10-K and its most recent Quarterly Report on Form 10-Q. Dolby disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.
About Dolby Laboratories
Dolby Laboratories (NYSE:DLB) develops and delivers products and technologies that make the entertainment experience more realistic and immersive. For four decades, Dolby has been at the forefront of defining high-quality audio and surround sound in cinema, broadcast, home audio systems, cars, DVDs, headphones, games, televisions, and personal computers. Based in San Francisco with European headquarters in England, the Company has entertainment industry liaison offices in New York and Los Angeles, and licensing liaison offices in London, Shanghai, Beijing, Hong Kong, and Tokyo. For more information about Dolby Laboratories or Dolby technologies, please visit www.dolby.com.
Dolby and the double-D symbol are registered trademarks of Dolby Laboratories. S06/17683 DLB-F
| DOLBY LABORATORIES, INC. | ||||||||||||
| CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||||||
| Fiscal Quarter Ended | Fiscal Year Ended | |||||||||||
|
September 30, 2005 |
September 29, 2006 | September 30, 2005 | September 29, 2006 | |||||||||
| (unaudited) | ||||||||||||
| (in thousands, except per share amounts) | ||||||||||||
| Revenue: | ||||||||||||
| Licensing | $ | 58,615 | $ | 80,360 | $ | 246,298 | $ | 301,663 | ||||
| Product sales | 15,241 | 14,839 | 60,021 | 65,413 | ||||||||
| Production services | 5,068 | 6,944 | 21,648 | 24,466 | ||||||||
| Total revenue | 78,924 | 102,143 | 327,967 | 391,542 | ||||||||
| Cost of revenue: | ||||||||||||
| Cost of licensing | 5,191 | 7,101 | 40,558 | 26,887 | ||||||||
| Cost of product sales (1) | 8,143 | 8,733 | 31,181 | 38,487 | ||||||||
| Cost of production services (1) | 2,037 | 2,755 | 8,479 | 10,668 | ||||||||
| Total cost of revenue | 15,371 | 18,589 | 80,218 | 76,042 | ||||||||
| Gross margin | 63,553 | 83,554 | 247,749 | 315,500 | ||||||||
| Selling, general and administrative (1) | 33,316 | 40,567 | 135,155 | 154,165 | ||||||||
| Research and development (1) | 7,618 | 9,964 | 30,532 | 35,377 | ||||||||
| Gain on settlements | - | (3,625) | (2,000) | (3,625) | ||||||||
| Total operating expenses | 40,934 | 46,906 | 163,687 | 185,917 | ||||||||
| Operating income | 22,619 | 36,648 | 84,062 | 129,583 | ||||||||
| Other income, net | 4,056 | 4,741 | 7,156 | 17,054 | ||||||||
| Income before provision for income taxes and controlling interest | 26,675 | 41,389 | 91,218 | 146,637 | ||||||||
| Provision for income taxes | 9,255 | 15,917 | 37,330 | 55,833 | ||||||||
| Income before controlling interest | 17,420 | 25,472 | 53,888 | 90,804 | ||||||||
| Controlling interest in net income | (612) | (255) | (1,595) | (1,255) | ||||||||
| Net income | $ | 16,808 | $ | 25,217 | $ | 52,293 | $ | 89,549 | ||||
| Basic earnings per share | $ | 0.16 | $ | 0.24 | $ | 0.54 | $ | 0.85 | ||||
| Diluted earnings per share | $ | 0.15 | $ | 0.22 | $ | 0.50 | $ | 0.80 | ||||
| Basic shares outstanding | 103,655 | 106,964 | 96,969 | 105,688 | ||||||||
| Diluted shares outstanding | 110,499 | 112,150 | 104,220 | 111,658 | ||||||||
| (1) Stock-based compensation included in net income above was as follows: | ||||||||||||
| Cost of product sales | $ | 56 | $ | 201 | $ | 222 | $ | 800 | ||||
| Cost of production services | 20 | 128 | 103 | 513 | ||||||||
| Selling, general and administrative | 2,245 | 3,146 | 11,709 | 15,087 | ||||||||
| Research and development | 428 | 723 | 2,150 | 2,738 | ||||||||
| Total stock-based compensation | $ | 2,749 | $ | 4,198 | $ | 14,184 | $ | 19,138 | ||||
| DOLBY LABORATORIES, INC. | ||||||
| CONSOLIDATED BALANCE SHEETS | ||||||
| September 30, 2005 | September 29, 2006 | |||||
|
(unaudited) |
||||||
| (in thousands) | ||||||
| ASSETS | ||||||
| Current assets: | ||||||
| Cash and cash equivalents | $ | 372,403 | $ | 412,487 | ||
| Short-term investments | - | 73,212 | ||||
| Restricted cash | 205 | 210 | ||||
| Accounts receivable, net | 25,221 | 23,550 | ||||
| Inventories | 11,722 | 11,104 | ||||
| Income tax receivable | 8,021 | 8,956 | ||||
| Deferred income taxes | 31,183 | 44,568 | ||||
| Prepaid expenses and other current assets | 5,433 | 6,130 | ||||
| Total current assets | 454,188 | 580,217 | ||||
| Property, plant and equipment, net | 76,462 | 76,995 | ||||
| Intangible assets, net | 17,184 | 14,954 | ||||
| Goodwill | 23,865 | 23,188 | ||||
| Long-term investments | - | 32,909 | ||||
| Long-term deferred income taxes | 6,781 | 11,100 | ||||
| Other assets | 7,797 | 7,510 | ||||
| Total assets | $ | 586,277 | $ | 746,873 | ||
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
||||||
| Current liabilities: | ||||||
| Accounts payable and accrued liabilities | $ | 65,126 | $ | 79,336 | ||
| Income taxes payable | 3,054 | 13,304 | ||||
| Current portion of debt | 1,346 | 1,441 | ||||
| Deferred revenue | 3,268 | 6,358 | ||||
| Total current liabilities | 72,794 | 100,439 | ||||
| Long-term debt | 12,124 | 10,893 | ||||
| Other non-current liabilities | 21,956 | 21,342 | ||||
| Total liabilities | 106,874 | 132,674 | ||||
| Controlling interest | 18,264 | 19,911 | ||||
| Stockholders' equity: | ||||||
| Class A common stock | 33 | 37 | ||||
| Class B common stock | 71 | 70 | ||||
| Additional paid-in capital | 308,354 | 323,449 | ||||
| Deferred stock-based compensation | (26,422) | - | ||||
| Retained earnings | 177,369 | 266,918 | ||||
| Accumulated other comprehensive income | 1,734 | 3,814 | ||||
| Total stockholders' equity | 461,139 | 594,288 | ||||
| Total liabilities and stockholders' equity | $ | 586,277 | $ | 746,873 | ||
| DOLBY LABORATORIES, INC. | ||||||||||||
| RECONCILIATION OF PRO FORMA NET INCOME TO ACTUAL NET INCOME | ||||||||||||
| Fiscal Quarter Ended |
Fiscal Year Ended |
|||||||||||
| September 30, 2005 | September 29, 2006 | September 30, 2005 | September 29, 2006 | |||||||||
| (unaudited) | ||||||||||||
| (in thousands, except per share amounts) | ||||||||||||
| Net income | $ | 16,808 | $ | 25,217 | $ | 52,293 | $ | 89,549 | ||||
| Add: | ||||||||||||
| Royalties payable to Ray Dolby (net of taxes) | - | - | 11,123 | - | ||||||||
| Pro forma net income | $ | 16,808 | $ | 25,217 | $ | 63,416 | $ | 89,549 | ||||
| Basic shares outstanding | 103,655 | 106,964 | 96,969 | 105,688 | ||||||||
| Diluted shares outstanding | 110,499 | 112,150 | 104,220 | 111,658 | ||||||||
| Basic net income per share | $ | 0.16 | $ | 0.24 | $ | 0.54 | $ | 0.85 | ||||
| Diluted net income per share | $ | 0.15 | $ | 0.22 | $ | 0.50 | $ | 0.80 | ||||
| Basic pro forma net income per share | $ | 0.16 | $ | 0.24 | $ | 0.65 | $ | 0.85 | ||||
| Diluted pro forma net income per share | $ | 0.15 | $ | 0.22 | $ | 0.61 | $ | 0.80 | ||||

